Ronen Tamir

Ronen Tamir, B.Sc., MBA, is a leader in Pharmaceuticals, Personalized Medicine, Digital Health, and Investor Relations, with over 30 years of experience in global markets. Starting his career as a sales representative, he then held multiple IR, Strategy, and P&L leadership positions at Serono, Novartis, GE Healthcare, Teva, and Pfizer, where he now serves as Vice President, Investor Relations.
His expertise spans drug development, regulatory affairs, and marketing. Notably, Ronen has excelled in investor relations, effectively communicating the strategic vision and growth potential of the organizations he has been a part of. His ability to build strong relationships with investors has been instrumental in the success of himself and the teams he is part of. As VP of IR, North America at Novartis, he won the IR Magazine “Best European IR Team in the US” award and, most recently, as part of the IR team at Pfizer, the IR Impact award for “Best Use of Technology, including AI” for the implementation of AI in the daily work of the IR team, a project he initiated in 2023 and continues to lead today.
In addition to his professional achievements, Ronen is passionate about mentoring the next generation of leaders in the healthcare sector. He is committed to fostering a culture of innovation and excellence, ensuring that the industry continues to evolve and meet the needs of patients worldwide.